ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) is conducting a webinar to give an update on the development of its Global Trade Item Number (GTIN) repository service.
Held in collaboration with channel data management and analytics solution provider ValueCentric LLC, the free webinar — titled “Origin: HDA’s Product Data Source” — is scheduled for Friday, April 28, at 11 a.m. to noon ET. Registration is required to participate in the webinar.
HDA said Origin will be a user-friendly central data repository aimed at ensuring efficient, accurate exchange of pharmaceutical product master data between manufacturers and supply chain partners, as required by the Drug Supply Chain Security Act (DSCSA). The Origin GTIN repository service is slated to go live in July.
“The traceability system mandated by the DSCSA will require a massive amount of frequent and accurate data exchange. GTINs must be up to date and correct to ensure the accuracy of master data,” according to Perry Fri, executive vice president of industry relations, education and membership at HDA. “We are excited to introduce the industry to Origin — which will provide a much-needed, central, uniform method for manufacturers to share product master data with multiple, direct and indirect trading partners to ensure this consistency — and committed to help its users every step of the way.”
HDA noted that the name “Origin” was selected for the data repository service because it’s intended as the fixed starting point of reference for all verified GTIN information. The repository will house primary information populated directly from pharmaceutical manufacturing companies. Origin will provide the base for critical data that the pharmaceutical supply chain must reference for DSCSA compliance.
The webinar will be led by Fri and Bill Henderson, executive vice president commercial development at ValueCentric. Topics to be covered include the role of GTINs within the DSCSA; how to register and format GTINs; the benefits of a central master data repository to manufacturers, distributors and other stakeholders; and next steps as well as the Origin launch plan.
“ValueCentric has been a proud collaborative partner that the pharmaceutical supply chain has relied upon for our expertise in secure data management, analytics and reporting,” Henderson stated. “We are pleased to have been a critical part in creating a user-friendly, industrywide solution for accurate data exchange and verification throughout the supply chain.”
Product specifications during the creation and testing of Origin are being overseen by a committee appointed from the HDA’s member community, representing large and midsize drug wholesalers and manufacturers. Companies interested in being included in the continued development of Origin can participate in the beta testing of the product.